美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

NEWAMSTERDAM PHARMA CO NV C/WTS 22/11/2027 (TO PUR COM)

17.50

0.0000

成交量：- -

成交額：8,259.50

市值：19.71億

市盈率：-8.67

高：17.50

開：17.50

低：17.50

收：17.50

52周最高：29.99

52周最低：7.16

股本：1.13億

流通股本：1.13億

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-2.0190

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

NewAmsterdam Pharma啓動Rubens三期臨床試驗，預計招募約300名患者，關鍵數據將於2026年底公布

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/NAMSW/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NAMSW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NAMSW\",,,,,undefined,":{"symbol":"NAMSW","market":"US","secType":"STK","nameCN":"NEWAMSTERDAM PHARMA CO NV C/WTS 22/11/2027 (TO PUR COM)","latestPrice":17.5,"timestamp":1777575062807,"preClose":17.5,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":112628458,"shares":112628458,"eps":-2.019,"marketStatus":"交易中","change":0,"latestTime":"04-30 14:51:02 EDT","open":17.5,"high":17.5,"low":17.5,"amount":8259.499897,"amplitude":0,"askPrice":22.23,"askSize":100,"bidPrice":15.92,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.019,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1777579200000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":17.5,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NAMSW\",,,,,undefined,":{"symbol":"NAMSW","floatShares":112628458,"roa":"--","roe":"--","lyrEps":0,"shares":112628458,"dividePrice":0,"high":17.5,"amplitude":0,"preClose":17.5,"low":17.5,"week52Low":7.155,"pbRate":"--","week52High":29.99,"institutionHeld":0,"latestPrice":17.5,"eps":-2.019,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.019,"open":17.5,"prevYearClose":23,"prevWeekClose":19.2,"prevMonthClose":20.04,"prevQuarterClose":20.04,"fiveDayClose":22.21,"twentyDayClose":20.04,"sixtyDayClose":20},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NAMSW\",params:#limit:5,,,undefined,":[{"date":"2026-02-18","symbol":"NAMSW","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771405200000,"name":null,"time":"盤前","dateTimestamp":1771390800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NAMSW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NAMSW\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NAMSW\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1131907867","title":"NewAmsterdam Pharma啓動Rubens三期臨床試驗，預計招募約300名患者，關鍵數據將於2026年底公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1131907867","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131907867?lang=zh_tw&edition=fundamental","pubTime":"2026-01-09 21:07","pubTimestamp":1767964048,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma Company Nv（简称NAMSW）已正式启动其名为“Rubens”的三期临床试验。根据公司规划，该项研究预计将招募约300名患者参与，旨在评估其候选药物的有效性与安全性。\n研究团队计划在2026年底前获得关键的顶线数据结果。这一时间表的设定，为市场观察者提供了明确的研究进展预期。若试验结果积极，将有望为公司的产品管线带来重要进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAMSW"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}]}}